Research Article
Therapy Efficacy of Idiopathic Ventricular Extrasystoles: A Real Life Study
Table 1
Patient characteristics and experienced symptoms categorized by follow-up success.
| | | Successful | Unsuccessful | value | | n = 26 | n = 9 | | n/mean/median | %/sd/Q1–Q3 | n/mean/median | %/sd/Q1–Q3 |
| | Female | 13 | 50.0 | 5 | 55.6 | | | Age | 49.5 | 17.1 | 56.5 | 9.9 | 0.369 | | BMI | 26.4 | 23.6–28.2 | 28.7 | 26.2–34.7 | 0.069 | | Hypertension | 7 | 26.9 | 3 | 33.3 | — | | Coronary artery disease | 3 | 11.5% | 1 | 11.1 | — | | DM2 | 0 | 0.0% | 1 | 11.1 | — | | LVEF | 60.0 | 57.3–65.8 | 60.0 | 55.0–66.5 | 0.940 | | LVEDD | 52.0 | 49.0–59.0 | 55.0 | 52.0–61.0 | 0.244 | | Palpitations | 25 | 96.2 | 8 | 88.9 | — | | Deteriorated physical health | 12 | 46.2 | 5 | 55.6 | — | | Dizziness/presyncope | 18 | 69.2 | 4 | 44.4 | — | | Syncope | 2 | 7.7 | 1 | 11.1 | — | | QT time | 407 | 38.6 | 434.0 | 26.3 | 0.610 | | QTc time | 423.6 | 39.0 (max. 515) | 448.8 | 33.0 (max. 500) | 0.930 | | Number of VES/24 h before ablation | 17,484.0 | 6,429.0−27,696.0 | 20,322 | 5,687.0−38,146.0 | — | | Number of VES/24 h after ablation | 135.0 | 13.0−1,366.0 | 16,529 | 8,162.0−34,534.0 | — | | Primarily successful ablation | 24 | (92.3%) | 2 | (22.2%) | 0.001 |
|
|
BMI, body mass index; DM, diabetes mellitus; EF, ejection fraction; LV, left ventricle; LVEDD, left ventricular end-diastolic diameter; VES, ventricular extrasystole.
|
